Key result
Emergency noncardiac surgery in patients on DAPT post-coronary stenting resulted in a 9.8% 180-day mortality, with early antiplatelet restart (<2 days) increasing bleeding risk.
Why the study?
The outcomes of patients on dual antiplatelet therapy after coronary stenting following emergency noncardiac surgery remain unclear.
What are the clinical outcomes of patients on dual antiplatelet therapy post-coronary stenting following emergency noncardiac surgery?
Cohort (n=133)
What are the clinical outcomes of patients on dual antiplatelet therapy post-coronary stenting following emergency noncardiac surgery?
In patients on DAPT post-coronary stenting undergoing emergency noncardiac surgery, 180-day mortality is approximately 10%, and early restarting of antiplatelets (<2 days) significantly increases bleeding risk.
Answers are grounded in this paper and cite their sources.
Caution advised with early DAPT restart in emergency surgery post-stenting; leaves open optimal timing for prospective trials.
BACKGROUND: The outcomes of patients on dual antiplatelet therapy (DAPT) post-coronary stenting following emergency noncardiac surgery remain unclear. METHODS: inhibitors. Our primary outcome was 180-day mortality in these patients. We investigated factors associated with bleeding within 180 days after surgery as our secondary outcome and exploratorily examined factors affecting 180-day mortality. RESULTS: Of 62,528 patients who underwent any surgery under general anaesthesia during the 11-year study period, 133 patients (0.22% of all and 1.41% of emergency surgical patients) were analysed. Among the eligible patients, 180-day mortality was 9.8% (13/133). Eighteen patients (13.5%) developed bleeding within 180 days after surgery, which was the most common post-operative complication. Restarting antiplatelet agents <2 days post-operatively (OR, 4.51; 95% CI, 1.56-13.0; P = 0.005) and stent implantation at bifurcation lesions before surgery (OR, 3.28; 95% CI, 1.07-10.1; P = 0.04) were associated with post-operative bleeding. Patients on haemodialysis had the worse prognosis (hazard ratio, 5.73; 95% CI, 1.87-17.5; P = 0.002) in terms of 180-day mortality. CONCLUSION: The 180-day mortality following emergency noncardiac surgery was approximately 10% in patients on DAPT post-coronary stenting. Restarting antiplatelet agents earlier than 2 days post-operatively and coronary stenting at bifurcation lesions were associated with bleeding within 180 days after surgery.
No takes yet. Share an insight, caveat, or question.
Irie et al. (2019) conducted a cohort in Dual antiplatelet therapy post-coronary stenting following emergency noncardiac surgery (n=133). Emergency noncardiac surgery while on dual antiplatelet therapy was evaluated on 180-day mortality. Emergency noncardiac surgery in patients on DAPT post-coronary stenting resulted in a 9.8% 180-day mortality, with early antiplatelet restart (<2 days) increasing bleeding risk.
Synapse has enriched 10 related papers. Consider them for comparative context: